India Equity Analyst - Fundamental & Thematic, Beat the Street

Sudarshan Bhandari

India Equity Analyst - Fundamental & Thematic

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

Equity Bottom-Up

Privi Speciality Chemicals / Equity Bottom-Up

<ul>
<li>Privi Speciality Chemicals, an aroma chemicals manufacturer, continues expanding its capacities and strengthening its product portfolio to support future growth and deepen its presence in global markets.</li>
<li>Privi operates a structurally strong business with backward integration, deep customer relationships, and proprietary processes, making it difficult for competitors to replicate its scale and margins.</li>
<li>Growth visibility remains strong with INR 5,000 crore revenue and INR 1,000 crore EBITDA targets, driven by capex and Givaudan JV, valuation depends on execution and scalability.</li>
</ul>


Privi Speciality Chemicals, an aroma chemicals manufacturer, continues expanding its capacities and strengthening its product portfolio to support future growth and deepen its presence in global markets.
Privi operates a structurally strong business with backward integration, deep customer relationships, and proprietary processes, making it difficult for competitors to replicate its scale and margins.
Growth visibility remains strong with INR 5,000 crore revenue and INR 1,000 crore EBITDA targets, driven by capex and Givaudan JV, valuation depends on execution and scalability.


Privi Speciality Chemicals: A Differentiated Player in Aroma Chemicals

<ul>
<li>SHK reported 12% revenue growth in H1 FY26, but the reported EBITDA margin was compressed due to significant, deliberate investments in new growth initiatives and higher insurance costs.</li>
<li>The margin compression is temporary, a function of strategic, discretionary capex and opex, which are critical for achieving the management's ambitious 18–20% EBITDA margin target by FY27–FY28.</li>
<li>The market is discounting the value of this forward-looking investment phase; sustained execution on new capacity, coupled with global regulatory shifts favoring organized players, provides a strong catalyst path.</li>
</ul>


SHK reported 12% revenue growth in H1 FY26, but the reported EBITDA margin was compressed due to significant, deliberate investments in new growth initiatives and higher insurance costs.
The margin compression is temporary, a function of strategic, discretionary capex and opex, which are critical for achieving the management's ambitious 18–20% EBITDA margin target by FY27–FY28.
The market is discounting the value of this forward-looking investment phase; sustained execution on new capacity, coupled with global regulatory shifts favoring organized players, provides a strong catalyst path.


The Beat Ideas: S.H. Kelkar - A Capex Cycle Poised to Unlock Operating Leverage

<ul>
<li>Gem Aromatics, a specialty ingredients manufacturer, opened its INR 450 crore IPO (Aug 19–21) at a INR 309–INR 325 price band. </li>
<li>The company supplies sticky, specification-heavy ingredients (mint derivatives, aroma chemicals) to marquee FMCG and F&amp;F players—segments benefiting from “China+1” and premiumisation in India.</li>
<li>Quality of customers and process capabilities are positives, but concentration, raw-material cycles and a pending land litigation temper enthusiasm, execution on citral scale-up is key.</li>
</ul>


Gem Aromatics, a specialty ingredients manufacturer, opened its INR 450 crore IPO (Aug 19–21) at a INR 309–INR 325 price band. 
The company supplies sticky, specification-heavy ingredients (mint derivatives, aroma chemicals) to marquee FMCG and F&amp;F players—segments benefiting from “China+1” and premiumisation in India.
Quality of customers and process capabilities are positives, but concentration, raw-material cycles and a pending land litigation temper enthusiasm, execution on citral scale-up is key.


Gem Aromatics IPO Analysis: A Niche Aroma Player

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Gem Aromatics (123GEM IN)

Privi Speciality Chemicals: A Differentiated Player in Aroma Chemicals

Privi Speciality Chemicals, an aroma chemicals manufacturer, strengthens its capacities and product portfolio to deepen global market presence.

Sudarshan Bhandari

The Beat Ideas: S.H. Kelkar - A Capex Cycle Poised to Unlock Operating Leverage

SHK's H1 FY26 EBITDA margin was compressed due to investments in growth initiatives and higher insurance costs. Margin compression is temporary,...

Sudarshan Bhandari

Gem Aromatics IPO Analysis: A Niche Aroma Player

Gem Aromatics opens INR 450 crore IPO, supplying specialty ingredients to FMCG and F&F players, facing challenges with concentration and raw...

Sudarshan Bhandari

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Privi Speciality Chemicals: A Differentiated Player in Aroma Chemicals

​Privi Speciality Chemicals, an aroma chemicals manufacturer, strengthens its capacities and product portfolio to deepen global market presence.

Sudarshan Bhandari

The Beat Ideas: S.H. Kelkar - A Capex Cycle Poised to Unlock Operating Leverage

​SHK's H1 FY26 EBITDA margin was compressed due to investments in growth initiatives and higher insurance costs. Margin compression is temporary,...

Sudarshan Bhandari

Gem Aromatics IPO Analysis: A Niche Aroma Player

​Gem Aromatics opens INR 450 crore IPO, supplying specialty ingredients to FMCG and F&F players, facing challenges with concentration and raw...

Sudarshan Bhandari

Privi Speciality Chemicals, an aroma chemicals manufacturer, strengthens its capacities and product portfolio to deepen global market presence.

SHK's H1 FY26 EBITDA margin was compressed due to investments in growth initiatives and higher insurance costs. Margin compression is temporary,...

Gem Aromatics opens INR 450 crore IPO, supplying specialty ingredients to FMCG and F&F players, facing challenges with concentration and raw...